T cell vaccinology: exploring the known unknowns
Matt A Burchill1, Beth A Tamburini, Nathan D Pennock
1Integrated Department of Immunology, University of Colorado Denevr and National Jewish Health, Denver, CO 80206, United States.
Vaccine
|November 10, 2012
Summary
Modern vaccine development aims for long-term immune memory. This review explores strategies for creating safer subunit vaccines that effectively induce cellular immunity, addressing limitations of current live attenuated and subunit vaccine approaches.
Area of Science:
- Vaccinology
- Immunology
- Biotechnology
Background:
- Live attenuated vaccines induce strong cellular and humoral immunity but have safety and production challenges.
- Subunit vaccines offer safety and stability but typically elicit weaker, primarily humoral, immune responses.
- Current subunit vaccines do not effectively induce cellular immune memory.
Purpose of the Study:
- To provide an overview of key research areas for developing vaccines capable of inducing robust and enduring cellular immune responses.
- To highlight strategies for improving subunit vaccine efficacy in generating cellular immunity.
- To address the limitations of existing vaccine platforms in eliciting long-term cellular immune memory.
Main Methods:
- Review of current vaccine development strategies.
- Analysis of the immunological mechanisms underlying cellular immune memory.
- Exploration of novel approaches for enhancing subunit vaccine immunogenicity.
Main Results:
- Live attenuated vaccines provide potent immunity but pose risks.
- Subunit vaccines are safer but lack cellular immunity induction.
- Significant gaps exist in developing subunit vaccines for cellular memory.
Conclusions:
- Developing effective subunit vaccines that induce cellular immune memory is a critical goal.
- Further research is needed to overcome the limitations of current subunit vaccine technology.
- Advancements in this area could lead to improved prophylactic and therapeutic vaccines.
Related Concept Videos
01:22T Cell Activation and Clonal Selection
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
01:27Cytotoxic T Cells-mediated Immune Response
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
01:51Vaccinations
Overview
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...